Unlocking the Future of Infectious Disease Research:
Emerging viral threats often stem from viral mutations, which can enhance a virus’s ability to infect hosts, evade immune responses, or become more virulent. An unfortunate example of this is
CARB-X global partnership headed toward developing an innovative vaccine against potentially deadly Staphylococcus aureus bacteria that could be a “game changer” in stemming antimicrobial resistance (AMR).
Subscribe to the IBT Bioservices Tech Talk list and receive periodic updates on industry news and IBT Bioservices products and services.
Emerging viral threats often stem from viral mutations, which can enhance a virus’s ability to infect hosts, evade immune responses, or become more virulent. An unfortunate example of this is
One of the most powerful applications of flow cytometry is for evaluating drug and vaccine efficacy. Multiparameter flow cytometry relies on the use of fluid systems, fluorescent proteins, and optical
The increasing rate of bacterial resistance creates a challenging environment for the development of therapies for bacterial infections. Bacterial skin infections are one of the leading manifestations of infectious diseases